Table 11. Distributions of PHQ9 and GAD7 based on clinical thresholds and gender.

PHQ9	[<10]		[>= 10]
	#	%	#	%
Male	186	54.7%	154	45.3%
Female	357	43.2%	469	56.8%
Whole	543	46.6%	623	53.4%
GAD7	[<8]		[>= 8]
	#	%	#	%
Male	193	54.7%	147	43.2%
Female	373	45.2%	453	54.8%
Whole	566	48.5%	600	51.5%